These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Supplementary Statement for the 2001-2002 season: influenza vaccination of persons who experienced oculo-respiratory syndrome following previous influenza vaccination. National Advisory Committee on Immunization (NACI). Can Commun Dis Rep; 2001 Nov; 27():1-7. PubMed ID: 11817153 [No Abstract] [Full Text] [Related]
4. [Further study of the reactogenic properties and safety of a killed influenza A/Scotland/74 vaccine]. Ranevskiĭ VD; Belov AB; Ivanov KG; Ishkil'din MI; Markelov IM Tr Inst Im Pastera; 1976; 47():121-3. PubMed ID: 802564 [No Abstract] [Full Text] [Related]
5. Influenza vaccination for healthy working adults. Nichol KL Minn Med; 1999 Nov; 82(11):24-6. PubMed ID: 10589210 [No Abstract] [Full Text] [Related]
6. Update on influenza A (H1N1) 2009 monovalent vaccines. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(39):1100-1. PubMed ID: 19816398 [TBL] [Abstract][Full Text] [Related]
7. Influenza vaccine oculorespiratory syndrome incidence is reduced in HIV. Cooper C; Thorne A; Vaccine; 2011 Oct; 29(45):7876-7. PubMed ID: 21872629 [TBL] [Abstract][Full Text] [Related]
10. An advisory committee statement (ACS). National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2003-2004 season. National Advisory Committee on Immunization Can Commun Dis Rep; 2003 Aug; 29():1-20. PubMed ID: 12961958 [No Abstract] [Full Text] [Related]
11. Influenza vaccines 1983-1984. Recommendation of the Immunization Practices Advisory Committee. Ann Intern Med; 1983 Oct; 99(4):497-9. PubMed ID: 6625385 [TBL] [Abstract][Full Text] [Related]
12. Influenza vaccine 2008-2009. Med Lett Drugs Ther; 2008 Oct; 50(1296):77-9. PubMed ID: 18833032 [TBL] [Abstract][Full Text] [Related]
13. Oculo-respiratory syndrome after influenza vaccination: trends over four influenza seasons. De Serres G; Toth E; Ménard S; Grenier JL; Roussel R; Tremblay M; Landry M; Robert Y; Rochette L; Skowronski DM Vaccine; 2005 May; 23(28):3726-32. PubMed ID: 15882534 [TBL] [Abstract][Full Text] [Related]
14. Statement on influenza vaccination for the 2001-2002 season. National Advisory Committee on Immunization (NACI), Health Canada Can Commun Dis Rep; 2001 Aug; 27():1-24. PubMed ID: 11501350 [No Abstract] [Full Text] [Related]
15. Randomized, double-blind, placebo-controlled trial to assess the rate of recurrence of oculorespiratory syndrome following influenza vaccination among persons previously affected. Skowronski DM; De Serres G; Scheifele D; Russell ML; Warrington R; Davies HD; Dionne M; Duval B; Kellner J; MacDonald J Clin Infect Dis; 2003 Oct; 37(8):1059-66. PubMed ID: 14523770 [TBL] [Abstract][Full Text] [Related]
17. [Vaccinal prevention of influenza in children]. Zykov MP; Vasil'eva RI Tr Inst Im Pastera; 1982; 58():30-8. PubMed ID: 6764981 [No Abstract] [Full Text] [Related]
18. Influenza vaccine: new recommendations for infants and children aged 6 to 23 months. Campos-Outcalt D J Fam Pract; 2004 Nov; 53(11):874-7. PubMed ID: 15527723 [No Abstract] [Full Text] [Related]
19. Influenza and pneumococcal immunization 'blitz' in an inner city area: downtown eastside of Vancouver, British Columbia. Buxton J; Weatherill S; Hockin J; Daly P Can Commun Dis Rep; 2000 Jul; 26(14):117-22. PubMed ID: 10943025 [No Abstract] [Full Text] [Related]
20. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2004-2005 season. Orr P; Can Commun Dis Rep; 2004 Jun; 30():1-32. PubMed ID: 15239483 [No Abstract] [Full Text] [Related] [Next] [New Search]